You are here

Pfizer/BioNTech seeks U.S. nod for updated COVID vaccine as booster in kids under 5

Primary tabs

Pfizer/BioNTech seeks U.S. nod for updated COVID vaccine as booster in kids under 5

Wed, 2023-03-01 17:10 — mike kraft

Pfizer/BioNTech seeks U.S. nod for updated COVID vaccine as booster in kids under 5 Pfizer Inc and its German partner BioNTech SE have applied for emergency use authorization of their Omicron-adapted COVID-19 vaccine in the United States as a booster dose for children aged six months through four years, the companies said on Wednesday. The Omicron-adapted vaccine is currently authorized by the U.S. health regulator as the third dose of the three-dose primary course of vaccination in the country for children in this age group. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

- Private group -

Log in or register to post comments

Workflow history

Revision ID	Field name	Date	Old state	New state name	By	Comment	Operations
			No state	No state

Page loaded in 0.500 seconds.